VOCEMIVY
Live / Applied — Extension of time to oppose received (as of 29 Oct 2025)
What this means for you
Not registered yet, but its 06 Feb 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99031163
- Mark type
- Stylized text
- Filed
- 06 Feb 2025
- Published for opposition
- 07 Oct 2025
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease
Owner
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
Prosecution history
- 07 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Oct 2025 — PUBLISHED FOR OPPOSITION
- 01 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Sept 2025 — ASSIGNED TO EXAMINER
- 04 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Feb 2025 — APPLICATION FILING RECEIPT MAILED
- 06 Feb 2025 — NEW APPLICATION ENTERED
- 29 Oct 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED